UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
_____________
Date of Report (Date of Earliest Event Reported): November 26, 1996
_____________
BIO-VASCULAR, INC.
-----------------
(Exact Name of Registrant as Specified in its Charter)
MINNESOTA 0-13907 41-1526554
--------- ------- ----------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
2575 UNIVERSITY AVENUE, ST. PAUL, MINNESOTA 55114-1024
------------------------------------------- ----------
(Address of Principal Executive Officers) (Zip Code)
Registrant's telephone number, including
area code: (612) 603-3700
--------------
ITEM 5. OTHER EVENTS.
Filed herewith and incorporated by reference is a press release of Bio-
Vascular, Inc. dated November 26, 1996.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
99.1 Press Release, dated November 26, 1996 (filed herewith
electronically)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIO-VASCULAR, INC.
(Registrant)
/s/ JOHN T. KARCANES
--------------------
John T. Karcanes
President and Chief Executive Officer
December 6, 1996
Dated: _____________________
3
INDEX TO EXHIBITS
Item No. Description Method of Filing
- -------- ----------- ----------------
99.1 Press Release, dated November 26, 1996 ....................filed herewith electronically